Snapshot from Jul 25, 2026 at 07:00 UTC. For live data and tracking: View Live
Business investor presentation

TelyRx presents at Virtual Investor Conference

Analysis based on 6 articles · First reported Jul 07, 2026 · Last updated Jul 08, 2026

Sentiment
20
Attention
1
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The event is a routine investor relations activity with limited market impact. It may increase visibility among investors but is unlikely to move the stock significantly.

Healthcare Pharmaceuticals

TelyRx Holdings Inc. Holdings Inc., a technology-enabled healthcare and online pharmacy platform, announced that its President and CEO Vanessa Slowey and CFO John Cascio will present live at the Global Technology Virtual Investor Conference hosted by Virtual Investor Conferences.com on July 9, 2026. The company recently achieved milestones including filling 1 million prescriptions, 35% sequential revenue growth, and listings on the TSX and OTC Markets Group. The presentation will be interactive, allowing investors to ask questions in real-time.

60 TelyRx Holdings Inc. achieved 35% sequential revenue growth
50 TelyRx Holdings Inc. filled 1 million prescriptions
30 TelyRx Holdings Inc. presented at conference
priv
TelyRx Holdings Inc. is the presenting company, highlighting its recent growth milestones and engaging with investors.
Importance 100.0 Sentiment 20.0
per
Vanessa Slowey, as CEO, will present at the conference, representing the company's leadership.
Importance 50.0 Sentiment 10.0
per
John Cascio, as CFO, will co-present, providing financial insights to investors.
Importance 30.0 Sentiment 10.0
exch
OTC Markets Group is mentioned as the operator of OTC Markets Group and a contact for the conference.
Importance 10.0 Sentiment 0.0
exch
TelyRx Holdings Inc. listed on TSX in April 2026, a recent milestone mentioned in the presentation.
Importance 10.0 Sentiment 5.0
cnt
TelyRx Holdings Inc. operates across 48 U.S. states, and the U.S. is its primary market.
Importance 5.0 Sentiment 0.0
govactor
TelyRx Holdings Inc. focuses on FDA-approved medications, but the FDA is not directly involved in this event.
Importance 5.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.